By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novagali Pharma 

1 rue Pierre Fontaine
Genavenir IV
Evry    F-91058  France
Phone: 33-1-69-87-40-20 Fax: 33-1-69-87-40-30


Drug Delivery

Company News
Santen Pharmaceutical to Buy Novagali Pharma for $136 Million 9/28/2011 6:50:17 AM
Biotech Novagali Pharma in Takeover Talks, Mulls IPO 4/14/2010 7:06:57 AM
Novagali Pharma Announces FDA Clearance of IND for Phase III of Catioprost(R), its Cationic Emulsion of Latanoprost in Patients With Glaucoma 5/5/2009 8:39:26 AM
Novagali Pharma Completed a New Phase II With Cyclokat(R) in Dry Eye 4/15/2009 10:22:17 AM
Novagali Pharma Presents Results of its Innovative Latanoprost Formulation for Glaucoma 2/27/2009 9:54:31 AM
Novagali Pharma Completes a EUR15 Million Fund Raising 9/26/2008 6:25:20 AM
Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema 4/24/2008 6:36:47 AM
Novagali Pharma Announces the Launch of Cationorm(R) The Innovative Cationic Emulsion for the Treatment of Dry Eye Symptoms 4/10/2008 7:04:52 AM
Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia(R) in Children Suffering From Vernal Keratoconjunctivitis 6/25/2007 12:27:38 PM
Novagali Pharma Strengthens its Executive Management 6/20/2007 12:05:25 PM